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FROM YOUNG TO OLD: THE EFFECTS OF SEDENTARY-AGING AND EXERCISE
INTERVENTIONS ON STRUCTURAL PLASTICITY OF LUMBAR MOTOR
NEURONS, NMJ, AND GLIAL CELL LINE-DERIVED
NEUROTROPHIC FACTOR EXPRESSION

Alberto F. Cintrón-Colón, Ph.D.
Western Michigan University, 2022

Neuromuscular weakness has been associated with age progression. A possible reason is
a disconnection between muscle and neuron, causing components from both the central and
peripheral nervous systems to deteriorate. Exercise, however, has beneficial effects for both
muscle and nervous tissue, inducing neuroprotection. Neurotrophic factors are powerful
regulators of neuronal maintenance and synaptic strength. Glial cell line-derived neurotrophic
factor (GDNF) is a neurotrophic factor that has been shown to be a potent survival factor for
somatic motor neurons that innervate skeletal muscle.
This study aims to evaluate changes in structural plasticity of motor neurons in the
lumbar spinal cord and neuromuscular junction structures, and expand our understanding of the
regulatory processes controlling GDNF expression with sedentary aging and exercise. We
hypothesize that motor neuron area and possibly subgroups decrease with sedentary-aging, but in
exercised age-matched animals, the area will increase and subgroup diversity will remain stable.
At the site of the skeletal muscle, we hypothesize that NMJ structures get degraded with
sedentary-aging, but exercise can maintain those structures. Furthermore, we hypothesize that
exercise will increase GDNF protein content and expression in lumbar and muscle tissue.

Lumbar spinal tissue, soleus, plantaris and gastrocnemius were taken from sedentary and
exercised Sprague-Dawley rats between 1 month and 24 months of age. Sedentary groups
consisted of 1-month-old, 3-month-old, 6-month-old, 12-month-old, 18-month-old, and 24month-old rats, while exercised groups consisted of 3-month-old rats that had access to running
wheels for ten weeks and 12-, 18-, and 24-month-old rats that had access to running wheels for 6
months. Lumbar spinal tissue, soleus and plantaris were used for immunohistochemical analysis.
For spinal tissue, antibodies against choline acetyltransferase (ChAT), neuronal nuclei (NeuN),
and the fluorescent dye DAPI were used to identify neurons in the lateral motor column of the
ventral horn of the spinal cord. In skeletal muscle, a-bungarotoxin was used to identify end
plates. Lumbar spinal tissue, soleus and plantaris muscle were used for enzyme-linked
immunosorbent assay and gastrocnemius muscle was used for RT-qPCR.
Results suggest a decrease in area of neurons after 6 months of age. Exercised animals
had a larger area when compared to their respective sedentary age-matched group. Histogram
analysis suggests that larger neurons tend to be less numerous in adulthood. The area of end
plates from exercised rats was more prominent than their respective sedentary age-matched
counterpart. Our results aid in understanding the structural changes that can occur with aging in
the neuromuscular system in a mammalian model of aging. Soleus and plantaris muscle from
exercised rats showed incremented levels of total and concentration of GDNF protein content.
On the other hand, exercise did not have an effect on GDNF protein concentration in spinal cord.
GDNF expression increased in gastrocnemius in the 3-month-old exercised group. The results
aid in understanding the activity-dependent regulation of GDNF protein production and
expression. Furthermore, this work adds to the pool of knowledge of how exercise can impact at
different points in the lifespan of an aging mammalian model and its potential benefits.
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CHAPTER I
INTRODUCTION
Aging population and sarcopenia
According to the World Health Organization, by the year 2030, 1 in 6 people (~17%) will
be aged 60 years and higher increasing to a total of 1.4 billion individuals. By the year 2050,
there will be close to a doubling with 2.1 billion individuals and the population aged 80 years or
higher approximately 246 million individuals. Health costs related to loss of muscle mass are
around $18.5 billion, which represents 1.5% of the total national healthcare cost (Janssen et al.,
2004).
A common problem or sign of aging is the weakening of the neuromuscular system and
loss of skeletal muscle mass and function, also known as sarcopenia or senile muscle atrophy
(Marcell, 2003; Gustafsson and Ulfhake, 2021). As a consequence of skeletal muscle mass loss,
physical incapacity and frailty increase, resulting in independence reduction. An estimated 45%
of the older population in the USA is affected by sarcopenia, equivalent to 18 million people (in
2010) (Janssen et al., 2004).
The start of sarcopenia has been suggested to start in the fifth decade of life with declines
in muscle mass (annual rate of 0.8%) and strength (annual rate of 1-3%) although there have
been reports that it can start as early as the third decade (Goodpaster et al., 2006; Daly et al.,
2013; White et al., 2013; Gustafsson and Ulfhake, 2021). Causes for sarcopenia remain under
debate. More specifically if the origin of the disease is nervous system related or myogenic
(Gustafsson and Ulfhake, 2021).
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Motor neurons and aging
The effects of aging on motor neurons (MNs) is highly debated. Previous work from Jacob
characterized MNs in the lumbar region of the spinal cord of 6-month-old (mature) and 22month-old (old) Fischer 344 rats. In this study, MNs appeared less numerous in the old rats
compared to mature groups, however, the size of the cells were comparable. Additionally, it was
noticed that nucleolar diameter was larger in the older rats (Jacob, 1998). Other work by
Tomlinson & Irving used spinal cords from humans aged between 13 and 95 years. MNs from
the lumbo-spinal segments were counted and found no loss of cells up to 60 years of age but
after the age of 60 the number dropped (Tomlinson and Irving, 1977). Piekarz et al. studied
changes related to aging in the spinal cord. The researchers noticed an age-dependent loss ɑMNs number in old mice. When the ventral horn of 24-27 month old mice was compared to the
3-6 month old groups there was a 41% decrease of MNs. Additionally, caspase-3 activation and
glutamate levels were measured. There was a significant increase in cleaved caspase-3 and
increase glutamate levels in the spinal cord suggesting an increase in apoptosis and MN
vulnerability (Piekarz et al., 2020).
Conflicting research by Chai et al. using 3- (young) and 29-month-old (old/geriatric)
C57BI/6J mice found no difference in the number and size of MNs in the lumbar spinal cord. On
the other hand, the researchers found significant denervation of the neuromuscular junction
(NMJ) in the geriatric group (Chai et al., 2011). Maxwell et al. studied the effects of aging on
MNs in the spinal cord in two models with distinct average lifespans: rhesus monkey and
C57/BL6 mice. In both models, MNs maintained cell body size, suggesting no atrophy with
aging, however cellular waste or lipofuscin profile varied indicating that MNs age at different
rates. Additionally, they found a decrease in synaptic inputs of MNs (Maxwell et al., 2018).
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Sarcopenia – nervous system and muscle fiber aging
Proper muscle force is dependent on recruitment of muscle fibers, More specifically
innervation by one MN to one or several muscle fibers known as the motor unit (MU). MUs are
classified as slow-twitch fatigue-resistant, fast-twitch rapidly fatigable and intermediate fasttwitch fatigue-resistant (Burke et al., 1973; Burke, 1999). MNs that innervate muscle fibers are
influencers on the phenotype of these fibers, being either slow-twitch or fast-twitch (Buller et al.,
1960).
Recordings that have used both aged animals and humans show that number of MUs
either decline with age and some get remodeled. Remodeling of MUs is caused by re-innervation
of denervated fibers (McNeil et al., 2005; Power et al., 2016). Aging-induced atrophy affects
mostly type II myofibers based on peripheral nerve conduction velocity, latency, amplitude and
time course of the myofibers response recorded by EMG and muscle histology (Larsson, 1978;
Lexell et al., 1983). When denervated fast type fibers get innervated by slow-MNs, the fiber coexpresses slow myosin heavy chain and is clustered towards slow fibers nearby (Rowan et al.,
2012; Piasecki et al., 2018).
Previous work used retrograde tracing on motor axons in an aged model with sarcopenia
to track MNs. Approximately 30% of MNs were lost or had impaired axonal transport.
Interestingly, the effect was more noticeable in the lower limbs when compared to the upper
limbs (Hashizume and Kanda, 1995). Additionally, MNs in aged rodent spinal cords have a
higher level of calcitonin-gene-related protein (CGRP) and GAP43. These increased levels
suggest that a sizeable amount of MNs are involved in the processes of denervation and reinnervation process of the target muscles (Johnson et al., 1995). The effects of CGRP remains
ambiguous but it has been suggested to maintain end plates at times of denervation, increase
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acetylcholine quantal size, expressed, more favorably, by the MNs of fast MUs and in MNs
disconnected from their target tissue or in the process of collateral reinnervation (Piehl et al.,
1993; Johnson and Duberley, 1998; Gaydukov et al., 2016; Machado et al., 2019).
Decline and atrophy of muscle fibers, most noticeably on fast-twitch muscle fibers and
fiber type grouping have been associated with aging (Gustafsson and Ulfhake, 2021).
Additionally, muscle fibers from aged models show irregularities on end plates, increment in
lipid droplets, and increment in number of fibers with an intermediate pattern between slow and
fast muscle fibers (Lexell et al., 1983; Bowen et al., 2015; Larsson et al., 2019).
Spinal cord – anatomy
The central nervous system is composed of two organs the brain and the spinal cord (SC).
The SC innervates extremities (arms and legs), trunk and portion of the neck and viscera making
this organ responsible of motor, somatosensory and visceral innervation. This organ has 4
regions based on their location: cervical, thoracic, lumbar and sacral. Within the SC there are two
distinct enlargements, cervical and lumbar, containing neurons that innervate the extremities.
The SC has two masses; one made out of white matter and the other composed of great matter.
Gray matter is derived from the mantle layer of the neural crest and white matter is derived from
the marginal zone (Ko, 2019). The gray matter mass is divided in three horns (ventral, lateral and
dorsal horn), while the white matter is divided in three funiculi (ventral, lateral and dorsal
funiculus).
Gray matter in the SC is further divided into 10 zones named lamina. The zones in the
laminar map or Rexed laminae are named with roman numerals from I – X. Lamina IX is located
in the ventral horn, the region where alpha (ɑ)- and gamma (γ)- MNs are located. The neurons
found in lamina IX are somatotopically organized. The medial-most neurons innervate axial and
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proximal limb skeletal muscles, lateral-most neurons innervate the distal limb muscles, and
ventral-most neurons innervate the extensor muscles (Ko, 2019).
Motor neuron – characteristics, function and location
MNs are cells located in the central nervous system used to trigger contraction and
therefore movement control of the approximately 320 bilateral pairs of skeletal muscles found in
humans (Kanning et al., 2010). There are two main types of MNs: upper MNs originating in the
cerebral cortex and lower MNs found in the brainstem and spinal cord (Stifani, 2014). The focus
of this chapter will be on lower MNs.
Spinal MNs are located in the ventral horn of the spinal cord (Stifani, 2014). The axons
branching out of the spinal MNs, in a mammalian, can extend several meters to reach muscle
fibers making these the longest cell types (Stifani, 2014; Zayia and Tadi, 2021). These MNs are
cholinergic and can receive input from upper MN, sensory neurons and interneurons. Due to the
input it receives, spinal MNs play a role in the somatic reflex arc. When muscle spindles in
skeletal muscle gets stimulated and stretched, a signal is sent via afferent nerve fibers which
synapses with MNs (more specifically ɑ-MNs) in the case of a monosynaptic reflex or with an
interneuron in a polysynaptic reflex. The ɑ-MN, then, innervates the effector target, in this case
the skeletal muscle, which permits a fast muscle response (Héroux, 2017; Zayia and Tadi, 2021).
Motor neuron subtypes
Within lower MNs, three groups exist based on the target they innervate. These include:
branchial, visceral and somatic MNs. Branchial MNs are localized in the brainstem and along
with sensory neurons form the cranial nuclei. This combination innervates face and neck muscles
that derive from the branchial arch (Stifani, 2014; Han et al., 2018). Visceral MNs are associated
with the autonomic nervous system and control smooth muscle and glands (Stifani, 2014).
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Somatic MNs innervate skeletal muscle fibers and allow for movement. Within somatic MNs
there are various subtypes that include ɑ-, beta (ß)-, and γ-MNs (Kanning et al., 2010; Stifani,
2014).
ɑ-MNs receive input, integrate and relay motor commands to skeletal muscles. These
cells only innervate extrafusal fibers making them an important player for muscle contraction. ɑMNs are needed to complete either a monosynaptic or polysynaptic spinal reflex circuit. These
groups of neurons can be divided in three subtypes depending on the extrafusal fiber type they
target. The three subtypes are: slow-twitch fatigue-resistant (SFR)-, fast-twitch fatigue-resistant
(FFR)-, and fast-twitch fatigable (FF)-neurons (Eccles et al., 1960; Stifani, 2014). Unfortunately,
there is no universal criteria or rule for distinguishing these different subtypes. However, there
are trends that aid in identifying each cell by using cell size, excitability and their firing pattern.
It is suggested that SFR-neurons have the smallest soma out of the three subtypes of ɑMNs. By having the smallest soma, SFR-neurons respond to lower stimulation threshold because
of their high resistance and can maintain continuous activity after the stimulus has ended.
Because of this, these neurons are recruited first when muscle contraction is occurring (Lee and
Heckman, 1998). FF-neurons, however, have the largest soma and fire after SFR-neurons have
been recruited adding strength to the stimulated muscle. FF-neurons have faster conduction
velocity at around 100m/s compared to 85m/s as seen in SFR-neurons (Burke et al., 1973;
Stifani, 2014). Not many details are known about FFR-neurons, but it has been suggested to have
physiological properties in-between the SFR- and FF-neurons.
ß-MNs out of the three subtypes of somatic MNs, ß-MNs are the least numerous and the
least characterized. These neurons innervate extrafusal and intrafusal skeletal muscle fibers
meaning they can control both muscle contraction and sensory feedback from muscle spindles
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(Bessou et al., 1965; Stifani, 2014). γ-MNs control the sensitivity of muscle spindles to stretch
The firing of these cells increase the tension of intrafusal fiber mimicking muscle stretch. γ-MNs
differ to ɑ- and ß-MNs by only receiving sensory inputs and do not have any motor function.
However, in the spinal reflexes, γ-MNs do cooperate by modulating muscle contraction (Eccles
et al., 1960; Kanning et al., 2010; Stifani, 2014).
Motor neuron development and organization
Newly formed MNs are grouped into motor columns, more specifically medial motor
column (MMC), hypaxial motor column (HMC), and lateral motor column (LMC). The MMC
projects towards muscles of the dorsal region, HMC towards muscles of the ventral body and the
LMC towards body limbs. Generation of motor columns is achieved by diffusible factors
expressed in a polarized manner and transcriptional interaction within and around the neural tube
(Dasen and Jessell, 2009; Kanning et al., 2010).
The group of MNs, within a motor a column, that innervate a single muscle is termed as a
motor pool. MNs within the pool have stereotyped positions based on their input-output
connectivity patterns (Romanes, 1964; Vanderhorst and Holstege, 1997). A general motor pool
contain all MN subtypes, with ɑ-MNs being two-thirds of the cells in the pool. However, the
ratio of SFR-, FF- and FFR-MNs varies (Friese et al., 2009; Kanning et al., 2010). In the course
of development, peripheral inductive factors and mutual hindrance of endogenous transcription
factors (like Hox genes) establish the molecular characteristics of motor pools (Dasen and
Jessell, 2009).
It has been suggested that the creation of motor pools involves a series of mechanisms
that display a graded organization of LMC MNs, starting with medial and lateral divisions,
ultimately leading to motor pools. LMC medial neurons are first created in the MN progenitor
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zone followed by the LMC lateral neurons. The lateral neurons migrate, moving through the
medial neurons, towards their final destination in the lamina IX of the ventral horn in the spinal
cord. Previous work has suggested that the final positioning of MNs in the ventral horn has to do
with the cadherin family of adhesion molecules. Upon reaching their final location, defined
clusters of subtypes of MNs within the medial and lateral division come together to form what
we know as motor pools (Hollyday and Hamburger, 1977; Lin et al., 1998; Sockanathan and
Jessell, 1998; Landmesser, 2001; Price et al., 2002; Bello et al., 2012; Astick et al., 2014).
Dewitz et al. further explored MN positioning by conducting a quantitative three-dimensional
analysis to understand the role of cell adhesive signaling. They found that the inside-out
migration is the first step in MN positioning and coordination of afadin and catenin signaling
performs motor pool organization (Dewitz et al., 2018).
After synapse formation in development, axons of surviving neurons compete for
synaptic territory. During this competition phase, a processed called pruning occurs. Pruning
involves a loss of terminal branches and synapses, making sure that correct and complete
innervation of a target occurs (Luo and O’leary, 2005). In development, polyneuronal
innervation by MNs occurs. This entails extensive branching towards muscle fibers causing each
muscle fiber to be innervated by several motor axons. As development continues, pruning occurs
until the final adult pattern is established. In an adult, each MN can innervate several muscle
fibers at the same time (up to 300 muscle fibers) forming what is known as the motor unit and
each muscle fiber is innervated by only one motor axon (Redfern, 1970; Brown et al., 1976).
Nerve and muscle - neuromuscular junction
A MU, as previously mentioned, can be defined as a MN and all the muscle fibers it
innervates. This communication between nerve and muscle is called the NMJ. The anatomy of
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this synapse starts with an axon extending from a MN in the spinal cord. The axon terminal
reaches the skeletal muscle fiber running through shallow grooves on the surface of the muscle
towards the postjunctional site called the motor end plate. The small space between axon
terminal and motor end plate is called the synaptic cleft. At this site, chemical communication
between presynaptic neuron and postjunctional skeletal muscle cell occurs.
The way a neuron communicates with a skeletal muscle cell starts with depolarization of
the axon terminal. After depolarization, voltage-gated calcium (Ca2+) channels open allowing
Ca2+ to enter the terminal. The entry of Ca2+ triggers synaptic vesicles, containing the
neurotransmitter acetylcholine, to move towards the edge of the terminal. Upon reaching the
edge of the terminal, the vesicle binds with the membrane in an area called the active zone. The
synaptic vesicle fuses with the membrane and release ACh by exocytosis. ACh travels across the
length of the synaptic cleft and reach ACh-receptors. This leads to excitation of muscle fibers
thus triggering muscle contraction and ultimately movement.
Neurotrophic factors
Neurotrophic factors (NFs) are a class of proteins that promote neuronal survival,
regulate cell proliferation and differentiation, modulate axonal and dendritic elaborations, and
regulate synaptic plasticity (Henderson et al., 1994; Yan et al., 1995; Zhu et al., 2008;
Morcuende et al., 2013; Cintrón-Colón et al., 2020). Upon synthesis and secretion, one of the
main functions of NFs is to facilitate communication between neurons and their target tissues
(Morcuende et al., 2013). Some NFs include nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), neurotrophin-4 (NT-4) belonging to the
neurotrophins family, ciliary neurotrophic factor belonging to the CNTF family, and our
neurotrophic factor of interest, glial cell line-derived neurotrophic factor (GDNF) belonging to
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the GDNF Family Ligands (GFLs) (Oppenheim et al., 1995a; Cobianchi et al., 2017).
GFLs have four members: GDNF, neurturin, persephin, and artemin. The members of
this family have low amino acid sequence homology, but all function as homodimers for the
activation of the tyrosine kinase rearranged during transfection (RET) receptor. The RET
receptor occurs in the central and peripheral nervous system during development (Sanicola et al.,
1997). GDNF and the rest of the GFLs use RET as a signaling receptor but RET can only be
activated in the presence of a co-receptor glycosylphosphatidylinositol-linked GDNF (GFRα)
(Sariola and Saarma, 2003).
GDNF
GDNF was originally isolated from cultured B49 rat glial cells and found to enhance the
survival and differentiation of dopaminergic neurons in primary cultures by promoting dopamine
uptake (Lin et al., 1993, 1994). The GDNF sequence places the protein in the cysteine knot
growth factor superfamily; and even though it has a low overall protein sequence similarity to
TGF-b2, the pattern of cysteine residues makes it a distant member of the TGF-b family (Lin et
al., 1993).
GDNF has two finger-like structures that makes contact with the GFRa receptor. The
location where N-linked glycosylation takes place is found close to the tip of one the finger-like
structures (Eigenbrot and Gerber, 1997; Silvian et al., 2006; Parkash et al., 2008). The Cterminal of the mature GDNF has been established as highly important for its binding property to
GFRa1 receptor and activation of Ret (Eketjäll et al., 1999; Parkash et al., 2008). In the Cterminal of mature GDNF we can find cysteines Cys131 and Cys133. These cysteines participate
in the formation of a ring structure by linking with Cys68 and Cys72 (Oh-hashi et al., 2009).
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Shortly after the discovery of GDNF, multiple researchers began identifying which cell
types in the mammalian body contained and produced GDNF (Springer et al., 1995). GDNF
protein is widely distributed throughout both the central and peripheral nervous systems.
Synthesis and secretion of GDNF occurs in many cell types such as glial cells like astrocytes,
oligodendrocytes, and Schwann cells, motor neurons (MNs), and skeletal muscle. GDNF
signaling has also been found within the normal growth and morphogenesis of the ureteric bud in
developing kidneys, and in Sertoli cells in the testis (Henderson et al., 1994; Yan et al., 1995;
Yamamoto et al., 1996; Meng et al., 2000; Costantini, 2010).
GDNF has the most prominent effects on enteric, sympathetic, and dopamine neurons,
but it has been identified as a potent neurotrophic factor for regulating MN survival in the
peripheral nervous system (Henderson et al., 1994). GDNF prevents apoptosis of MNs during
development in vivo (Oppenheim et al., 1995a), decreases the loss of MNs in animal models of
motor neuropathy and degeneration, rescues MNs from axotomy-induced cell death, and protects
MNs from chronic degeneration (Li et al., 1995; Trupp et al., 1995; Airaksinen and Saarma,
2002; Sariola and Saarma, 2003; Ruven et al., 2018).
GDNF synthesis
GDNF is a secretory protein that is first formed as a precursor of 211 amino acids in
mammalian cells. The pre-sequence leads the protein to the endoplasmic reticulum for secretion.
As secretion takes place, the protein folds with sulfide (S-S) bonds, dimerizes, and later modified
by N-linked glycosylation. After modification, it undergoes proteolytic processing into its mature
form of 134 amino acids. This cleavage is due to a proteolytic consensus sequence located in
exon II (Lin et al., 1993, 1994; Piccinini et al., 2013).

11

Proteases that cleave of proGDNF to mature GDNF are furin, PACE4, and protein
convertases PC5A, PC5B, and PC7 (Lonka-Nevalaita et al., 2010). The protein convertase
family is responsible for posttranslational modifications of GDNF by cleaving five consensus
sites giving rise to four different forms of GDNF. In addition, GDNF proteins with a mutation in
the established furin-consensus sequence were secreted as unprocessed forms or forms with
lower molecular weights compared to mature forms obtained from wild-type GDNFoverexpressing C6 cells used by Oh-hashi et al., suggesting that GDNF can be secreted with or
without processing by furin-like proteases (Immonen et al., 2008; Oh-hashi et al., 2009).
Proper glycosylation is required for correct processing of GDNF protein. Piccinini and
colleagues developed a mutant variant with an altered amino acid sequence affecting the folding
of the protein. The mutant was compared to wild-type GDNF (with unchanged sequence) that
was expressed in the presence of tunicamycin. Tunicamycin is an inhibitor of N-linked
glycosylation, and when GDNF was expressed in its presence, the processing of the protein was
similar to the mutant’s. This data demonstrates that glycosylation is necessary for proper folding
and processing of GDNF protein in mammalian cells. The mutation at the glycosylation site
hindered cleavage of proGDNF into mature GDNF (Piccinini et al., 2013). Even though
glycosylation is important for folding, it is not critical for receptor activation. The investigators
showed that the unglycosylated protein, lacking the pro- sequence, is able to activate RET via
GFRa1 and 2 (with less affinity) (Piccinini et al., 2013).
Humans and rodents possess a short GDNF mRNA transcript with a 78 base pair deletion
at the very end of GDNF exon I, which results in a 26 amino acid deletion in the pro-region of
the protein. The deletion in the GDNF isoform does not affect the protein proteolytic sequence
(Schaar et al., 1994; Cristina et al., 1995; Wang et al., 2008). After alternative splicing, GDNF
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gene encodes two mRNAs, a full-length pre-(a)pro-GDNF and a shorter pre-(b)pro-GDNF, both
are cleaved to mature GDNF (Suter-Crazzorola and Unsicker, 1994; Matsushita et al., 1997;
Grimm et al., 1998; Penttinen et al., 2018).
Lonka-Nevalaita and colleagues (2010) used primary cortical neurons and the PC-6.3
cell line (neuroendocrine cells) to study intracellular processing and secretion mechanisms
encoded by the (a)pro-GDNF and (b)pro-GDNF isoforms (Pittman et al., 1993; Lonka-Nevalaita
et al., 2010). The research group found that when an increase in K-Cl induced depolarization
occurs, (b)pro-GDNF and its corresponding mature GDNF secretion increased, but there was no
increase of (a)pro-GDNF and its corresponding mature GDNF. Immunofluorescence analysis
reveals that (a)pro-GDNF and its corresponding mature GDNF was mostly localized in the
Golgi complex and colocalizes with Rab3A and Rab27A (two markers for secretory granules).
Furthermore, after stimulation there is a gradual movement along the secretory pathway. In
contrast, (b)pro-GDNF and its corresponding mature GDNF is mainly localized in secretogranin
II and Rab3A and Rab27A-positive vesicles and after stimulation there is a more rapid
movement along the secretory pathway (Wang et al., 2008; Lonka-Nevalaita et al., 2010).
GDNF secretion and internalization
Oh-hashi et al., established stable C6 cells that overexpressed GDNF allowing them to
monitor spontaneous release of the protein, as well as its processed forms in the cells. The
researchers increased GDNF secretion by stimulating the cells with high potassium and inhibited
glycosylation with tunicamycin or disturbed ER-Golgi transport with brefeldin A. The wild-type
GDNF-overexpressing C6 cells secreted three forms of processed GDNF. After treatment with
tunicamycin, GDNF secreted with the highest molecular weight showed the same mobility on
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electrophoresis as recombinant human GDNF missing a whole pro-domain (Oh-hashi et al.,
2009). When mutations occurred in the pro-domain and two cysteines located at the C-terminal
of GDNF protein secretion to the culture medium was significantly decreased. This data suggests
that pro-domains and C-terminal cysteines of GDNF have a critical role in its processing and
secretion in cultured astrocytes and C6 cells (Oh-hashi et al., 2009).
For GDNF internalization, encapsulation of the neurotrophic signal by endocytosis of
both receptor and ligand occurs. RET receptor when activated by GDNF has been uncovered to
associate with AP2 and clathrin at the plasma membrane and possibly facilitating clathrinmediated endocytosis similarly to NGF (Beattie et al., 2000; Howe et al., 2001; Crupi et al.,
2015). Further studies are required to understand long distance trafficking of GDNF.
SorLA is a member of the sortilin-related receptor family that is unified by the vacuolar
protein sorting protein 10p domain (Jacobsen et al., 1996; Willnow et al., 2008; Glerup et al.,
2013). SorLA possesses a cytoplasmic tail with a number of consensus binding sites for adaptor
proteins that aid internalization from the cell surface, Golgi-endosome transport, and retrograde
sorting to the trans-Golgi network (Nielsen et al., 2007). Glerup et al. (2013) studied the
mediating interactions of SorLA as a sorting receptor for the GDNF/GFRa1 complex, leading
the complex from the cell surface to endosomes. GDNF subsequently is targeted by lysosomes
and GFRa1 is recycled, thus making an effective clearance pathway. Furthermore, the
SorLA/GFRa1 complex targets RET for endocytosis but not for degradation, which affect
neurotrophic activities caused by GDNF like the survival of primary dopaminergic neurons
(Glerup et al., 2013). Further studies are needed to understand GDNF internalization and
trafficking.
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GDNF signaling
As previously reviewed by Sariola and Saarma, ligand-binding specificity for the GFLs is
dependent on the GFRα receptor proteins. There are a total of four GFRα proteins that interact
with the GFLs: GFRα1, GFRα2, GFRα3, and GFRα4. GDNF preferably binds to GFRα1, but
studies using GFRα1 knockout mice suggest that GDNF can act via GFRα2 with less affinity
(Schuchardt et al., 1994; Jing et al., 1997; Cacalano et al., 1998; Enomoto et al., 1998; Sariola
and Saarma, 2003).
GDNF is only functional as a homodimer stabilized by a disulfide bond. GDNF first
binds to a lipid raft-resident glycosylphosphatidylinositol (GPI) anchored GFRα1 receptor and
forms a high-affinity complex. This complex brings two RET molecules causing
transphosphorylation of specific tyrosine residues in their domains and intracellular signaling
(Strömberg et al., 1993; Trupp et al., 1995; Jing et al., 1996; Butte, 2001; Airaksinen and
Saarma, 2002; Sariola and Saarma, 2003; Cintrón-Colón et al., 2020). The activation of RET
triggers the mitogen activated protein kinase (MAPK), phosphoinositositide-3-kinase (PI-3K),
Erk, and Akt pathways which are attributed to act in promotion of cell survival (Airaksinen and
Saarma, 2002; Sariola and Saarma, 2003; Kim and Kim, 2018).
Membrane microdomains are enriched with signaling proteins like the Src family kinases
(SFK) suggesting that these microdomains could function as a specialized signaling organelle
(Anderson, 1998). Work from Tansey et al. (2000) showed that to obtain maximal levels of
GDNF-mediated bioactivity and efficient downstream signaling, RET has to be recruited to lipid
rafts by GFRa1 receptors and interacts with SFKs found in these microdomains. In addition,
SFKs only interact with RET when the receptor is located on the membrane microdomains
(Tansey et al., 2000). Encinas et al. studied the RET-SFK association in downstream signaling
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caused by GDNF. The researchers found SFK activity, in particular p60Src, was needed for best
GDNF-mediated Akt and MAPK phosphorylation. Additionally, Src promoted neuronal survival
through PI-3K pathway activity. When a PI-3K inhibitor is used, it prevented GFL-mediated and
Src-mediated neuronal survival, but it had no effect on NGF-mediated survival, suggesting Src
was particular for the GFL-mediated neuronal survival. Taking this data together, researchers
suggest Src as major signaling molecule for GDNF-mediated bioactivity (Encinas et al., 2001).
GFRa is more widely expressed in the nervous system compared to RET (Trupp et al.,
1997; Yu et al., 1998). That being the case, GFRa receptors should have an alternate way to
signal, independent from RET, probably with novel transmembrane proteins (Poteryaev et al.,
1999; Trupp et al., 1999). Neural cell adhesion molecule (NCAM) is an adhesion molecule found
in the nervous system and skeletal muscle, and it is involved in cell migration, synaptic
plasticity, and neurite outgrowth during development (Schachner, 1997; Crossin and Krushel,
2000; Rønn et al., 2000). Paratcha et al. studied RET-independent signaling by GDNF in both
glial and neuronal cells. They found a compelling similitude with intracellular pathways that
were activated by the p140NCAM NCAM isoform. The researchers demonstrated that the NCAM
isoform interacts directly with GDNF family ligands along with GFRa receptors, and mediate
GDNF signaling with no RET presence. GDNF acting via the NCAM pathway promotes
Schwann cell migration and axonal growth in cortical and hippocampal neurons (Paratcha et al.,
2003). GFLs, when GFRa receptors are present, can bind with p140NCAM and activate Src-like
kinase Fyn and focal adhesion kinase FAK, a nonreceptor tyrosine kinase that plays a role in
cytoskeletal rearrangement. GFLs can also bind directly to the NCAM isoform, but with much
less affinity and does not trigger any intracellular signaling. When GDNF is not present, and
GFRa1 receptor interacts with NCAM, it inhibits NCAM-mediated cell adhesion, suggesting
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potential difference in physiological effects, but further studies are required (Beggs et al., 1997;
Paratcha et al., 2003; Saarma, 2009; Kim and Kim, 2018).
Pozas and Ibáñez demonstrated that GDNF has the ability to promote differentiation and
migration of embryonic cortical GABAergic neurons that lack both RET and NCAM, suggesting
the existence of another receptor mediating GDNF-dependent processes in cortical development
(Pozas and Ibáñez, 2005; Bespalov et al., 2011). Bespalov et al. showed that GFLs (with the
exception of persephin) can use a different receptor. When GFLs are immobilized and matrixbound, they can associate with a transmembrane heparan sulfate (HS) proteoglycan called
syndecan-3. The researchers found GFL-syndecan-3 binding mediates neurite outgrowth and cell
spreading with the collaboration of Src kinase activation. Bespalov and colleagues discovered
that GDNF-syndecan-3 promote migration of cortical neurons, and when mice lack either one of
those components, they have a reduced number of GABAergic neurons (Bespalov et al., 2011).
Altogether, these studies suggest that GDNF may act through various pathways, mediating
growth, differentiation and migration of neurons. Once GDNF binds to one of its receptors, it
must be incorporated and transported.
Muscle-derived GDNF
Springer and colleagues (1995) reverse transcribed the total RNA from adult rat skeletal
muscle and amplified it for GDNF mRNA using PCR. They found two forms of GDNF and
noticed that one of the transcripts (GDNF633) was upregulated in denervated rat skeletal muscle
following 1-2 weeks of an axotomy procedure (Springer et al., 1995). In a similar fashion, Zhao
et al. (2004) studied the expression of GDNF mRNA present in four populations of skeletal
muscle: healthy skeletal muscle, denervated muscle, denervated muscle receiving sensory input,
and denervated muscle in which innervation was immediately repaired. Denervated muscle had
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the greatest GDNF expression, followed by levels in the muscle that received sensory protection,
and the muscle that underwent immediate repair. The healthy skeletal muscle had the lowest
levels of GDNF mRNA, providing strong evidence for increased expression of GDNF at times of
reinnervation of the NMJ (Zhao et al., 2004). These results provided further indications of the
roles of muscle innervation in determining the expression profile of alternatively spliced forms
of GDNF, GDNF working as a target-derived neurotrophic factor for neurons that innervate
skeletal muscle, and the effects of providing some sort of therapy on modulating GDNF
synthesis (Springer et al., 1995; Zhao et al., 2004).
Duchenne muscular dystrophy (DMD) is a genetic disorder that causes alterations in
dystrophin leading to muscle degeneration and frailty. A study done by Lie and Weis (1998)
examined the effects of denervation in human skeletal muscle on GDNF upregulation. The
researchers compared the expression of GDNF transcripts in healthy and denervated skeletal
muscle, and from muscle biopsies from DMD-positive patients. The researchers determined that
GDNF expression was significantly higher in muscle that was denervated when compared to
normal or DMD affected muscle (Lie and Weis, 1998). A possible reason for this result is that in
DMD patients partial innervation still exists and there is less pressure in trying to maintain nerve
to muscle contact when compared to denervated muscle. It is significant to note that work done
by Lie and Weis (1998) showed that GDNF mRNA expression in humans following denervation
follows a similar pattern like in rats (Springer et al., 1995; Lie and Weis, 1998; Zhao et al.,
2004). In addition, greater levels of GDNF were expressed in cases where a patient had a
rapidly-progressive neurogenic atrophy. GDNF expression in patients that had DMD were not
significantly different compared to the controls. Altogether, Lie and Weis (1998) demonstrated
evidence of the role of denervation and GDNF expression, but not dystrophy. We recommend
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further human studies are needed to provide more insight on the potential of using GDNF as a reinnervating and regeneration therapy.
Nguyen et al. generated a mouse model where muscle fibers make excess quantities of
GDNF. The researchers noticed GDNF overexpression caused hyperinnervation at the motor
end-plates found in muscle fibers. GDNF made in muscle could be acting as a synaptotrophin at
the NMJ. Interestingly enough, other neurotrophic factors like NT-3 and NT-4, when
overexpressed, did not provoke hyperinnervation of muscle fibers (Nguyen et al., 1998).
Retrograde transport of GDNF
Following the neurotrophic factor theory, the target cell releases a trophic “substance”.
This trophic substance is available in limited supply at the time of natural apoptosis during
development. The trophic factor released from the target cell reaches an axon terminal, and it is
shipped in a retrograde form to the cell body of the innervating neuron to promote survival
(Oppenheim, 1989). Retrograde spreading of a neurotrophic signal is performed by cellular
internalization of the neurotrophic factor along with its receptor at the distal location. After
internalization, compartmentalization into signaling endosomes occurs, followed by motor
protein-based transport towards the cell body (Wu et al., 2009; Zahavi et al., 2015, 2017).
Researchers have showed both retrograde and anterograde transport of GDNF, but further studies
are needed to better understand the physiological effects of anterograde transport in MNs
(Leitner et al., 1999; Russell et al., 2000; Haase et al., 2002; Rind and von Bartheld, 2002;
Zahavi et al., 2015).
Expression of GDNF in skeletal muscle suggests the existence of retrograde transport and
signaling from target tissue, even at adult ages (Henderson et al., 1994; Nguyen et al., 1998).
GDNF is considered the first MN-specific neurotrophic factor discovered (Treanor et al., 1996).
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Leitner et al. (1999) studied retrograde transport of some of the members of the GDNF family in
vivo. The researchers performed sciatic injections with radiolabeled GDNF and neurturin, then
used autoradiography to determine retrograde transport in MNs in the lumbar region of the spinal
cord in adult Sprague-Dawley rats. Examination of the spinal cord from the injected rats showed
more radiolabeled GDNF localized to ventral MNs compared to neurturin. This result shows
retrograde activity from GDNF and physiological differences in the actions of the GFLs (Leitner
et al., 1999).
Haase et al. (2002) studied MNs that express the erythroblast transformation specific
(ETS) transcription factor Pea3 in a mouse model. These MNs project their axons towards the
cutaneous maximus muscle and latissimus dorsi muscle, which show expression of GDNF. The
researchers noticed when GDNF is lost in skeletal muscle impaired motor nerve projection and
downregulation of Pea3 in MNs. Due to these findings, it is suggested that retrograde transport
of GDNF signaling is necessary for axon elongation and expression of Pea3 in neuronal cell
bodies. In addition, the axon promoting effects by GDNF is not merely a local event occurring in
target skeletal muscle (Haase et al., 2002; Ito and Enomoto, 2016).
Zahavi et al. (2015) developed an in vitro microfluidic platform that contained MN cell
bodies on one side and skeletal muscle cells on the other. The cell bodies and muscle cells were
connected by motor axons that extended through microgrooves to form NMJs that were
functional. The benefit of having this in vitro compartmentalized system is the opportunity to
study local versus distal signals, and monitoring of retrograde and anterograde transport (Taylor
et al., 2005; Zahavi et al., 2015). By using this model spatial specificity of the effects of GDNF
was characterized. When GDNF is added at the soma compartment, survival pathway signaling
via AKT is activated. In contrast, when GDNF is applied at the muscle compartment axonal
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growth at the axon tips and innervation of muscle cells is promoted. Additionally, the researchers
were able to visualize trafficking of GDNF in a retrograde fashion, from muscle cell to neuron
(Zahavi et al., 2015).
Sarcopenia – exercise as a preventative measure
Exercise in adult life preserves muscle functionality at adult and old ages (Trappe et al.,
1996; Bann et al., 2015; Drey et al., 2016). Furthermore, the importance of increased physical
activity is accentuated in times of immobilization, where loss of muscle mass and function is
increased (Wall et al., 2013). At old age, exercise tends to be limited, but remains an effective
preventative or intervention strategy (Bao et al., 2020). Exercise has been linked with slowingdown aging of the NMJ (connectivity between MNs and muscle fibers). A possible reason is the
increase in neurotrophic factor expression in exercised animals when compared to sedentary
counterparts in skeletal muscle (Love et al., 2003; McCullough et al., 2011; Gyorkos et al., 2014;
Mrówczynski, 2019; Stanga et al., 2020).
GDNF expression and exercise
Exercise is a potential approach to enhance functional recovery of central and peripheral
nerve injuries, delay neurodegenerative diseases, and has a potential for regulating neurotrophic
factor signaling (as reviewed by Cobianchi et al., 2017). It is still not completely understood how
physical activity could increase neurotrophic factor gene expression in active muscle. Wehrwein
et al. explored the changes in neuromuscular activity on GDNF content in rat skeletal muscle
(2002). Rats followed 4 weeks of walk-training on a treadmill and it was noticed that GDNF
protein content increased in the pectoralis major, soleus, and gastrocnemius muscle. Following
hindlimb unloading for two weeks GDNF protein content decreased in the soleus and
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gastrocnemius muscles, but increased in the pectoralis major suggesting that activity-dependent
regulation of GDNF occurs in rat skeletal muscle (Wehrwein et al., 2002)
McCullough et al. (2013) explored changes in GDNF protein levels in the spinal cord
following exercise. The researchers demonstrated that two weeks of either swimming or running
altered GDNF protein content levels in the lumbar spinal tissue of both young and old rats. The
L1-L3 lumbar region of the spinal cord was obtained from sedentary-control and exercised 6and 24-month old Sprague-Dawley rats. The spinal tissue was processed for GDNF protein
content for ELISA and Western blot assays. GDNF protein content significantly increased in
lumbar spinal tissue from exercised animals compared to sedentary age-matched animals
(McCullough et al., 2013). In addition, lumbar spinal cord sections were immunolabeled with
anti-choline acetyltransferase (ChAT) for somatic MNs (Wetts and Vaughn, 1996) and with antiGDNF. MN cell body size and vesicle-like structures of GDNF increased in spinal tissue from
the exercised rats compared to their sedentary counterpart (McCullough et al., 2013).
Using a similar exercise regimen, Gyorkos et al. (2014) discovered that two weeks of
running and swimming training can promote changes in GDNF expression and NMJ structure in
both slow- and fast- type muscles. GDNF protein content was measured using ELISA. There was
a significant increase of GDNF protein content level in the soleus muscle, while the extensor
digitorum longus (EDL) trended toward an increase in GDNF protein content (Gyorkos et al.,
2014). The morphology of the NMJ was analyzed by using a-bungarotoxin, which binds to
nicotinic acetylcholine receptors, thus labeling the post-synaptic end plates. The total area (µm2)
of post-synaptic end plates significantly increased in the soleus muscle following swimming
exercise compared to sedentary control animals. In contrast, the total area of end plates
significantly decreased in the EDL muscle after running training and no differences were noticed
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after swimming training (Gyorkos et al., 2014). Taken together, the work of McCullough et al.
(2013) and Gyorkos et al. (2014) demonstrate that physical exercise is sufficient to increase
GDNF protein content in the spinal cord, within skeletal muscles, and at the NMJ.
Park and Höke (2014) used a peripheral nerve regeneration model to study the impact of
treadmill exercise. The animals were divided in a control group, nerve repair without exercise
group and nerve repair with exercise group. Animals had the median nerve transected and
repaired, while the ulnar nerve was prevented from regenerating after the injury. The researchers
noticed that following a daily treadmill exercise regimen there was a higher number of axons
regenerated and increased myofiber size in the target muscles. There was an increment of various
neurotrophic factors that included GDNF, BDNF and insulin-like growth factor-1 (IGF-1) in
serum, muscle and nerve. Additionally, there was a faster functional recovery as demonstrated by
grip power and inverted holding test. Taken together, muscle derived neurotrophic factors, like
GDNF, and an appropriate exercise regimen might offer enhanced regeneration following injury
(Park and Höke, 2014).
GDNF therapy to treat peripheral nerve injuries
GDNF poses as a potential NF to treat peripheral nerve injuries (PNIs) in future human
trials, but delivery challenges exist. As reviewed by Eggers et al., understanding the proper
relationship between GDNF concentrations and duration of treatment to achieve adequate
therapeutic GDNF levels needs further studying. When high or low concentrations of GDNF are
prolonged, there is a tendency of axonal coil formation. In low-levels of GDNF, proper motor
neuron survival does not occur (Eggers et al., 2008, 2013, 2020; Santos et al., 2016; Wang et al.,
2018). Gene therapy is a powerful tool that can be hindered by the immune system. Making
finding ways to bypass the potential immune response is of great importance. Hoyng et al. and
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Eggers et al. have developed a successful way of doing so by developing a dox-i-GDNF system
discussed later in this section (Hoyng et al., 2014; Eggers et al., 2019).
Patients that suffer a brachial plexus injury, even after current surgical repairs, could
result in dysfunction and pain for the rest of the patient’s life (Eggers et al., 2020). Gene therapy
has been suggested as a form of delivering GDNF to treat peripheral nerve injuries. As reviewed
by Eggers et al. (2020), using gene therapy for GDNF can result in a continual supply of
biologically active protein limited to the site of injury or where the viral vector was applied. A
barrier for this approach is by-passing a potential immune response against the gene being
inserted. An additional obstacle that has to be tackled is the time of expression and amount of
expression (Tajdaran et al., 2016; Eggers et al., 2020). Eggers and colleagues (2019) completed a
preclinical study testing these challenges. The researchers developed an immune-evasive
doxycycline-inducible GDNF gene switch (dox-i-GDNF) with a time-restricted expression of
one month. With this novel GDNF delivery system, the researchers managed to reduce the
localized entrapment in avulsed reimplanted ventral spinal roots, promoted long-term motor
neuron survival, and augmented long-distance regeneration motor axons. These results provide
evidence that controlling the time of expression of GDNF can rectify the harmful effects of
uncontrolled GDNF delivery. Also, gene therapy can improve axon regeneration post-surgical
repair (Eggers et al., 2019).
An additional challenge for proper GDNF delivery is maintaining exogenous GDNF in
the correct location. Direct injection of the NF in a transplanted nerve tends to leak and causes
unorganized axonal regeneration in the leakage site (Fang et al., 2019). Differences between
distal and proximal stumps when treated with GDNF. When treated at the distal end, it did not
improve motor neuron survival, in contrast to the peripheral end (Eggers et al., 2008, 2019).
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A constant problem with PNIs is the length of the nerve gap after injury. If the nerve gap
is over two to three centimeters is considered a large nerve injury, and the standard remedy is
autografting (Dahlin, 2008; Fadia et al., 2020). PNIs that surpass three centimeters may
encounter challenges with unresponsive growth cones from the proximal stump to neurotrophic
factor signals released by the distal stump that lead axonal sprouting causing substandard nerve
regrowth (Deumens et al., 2010; Grinsell and Keating, 2014). Even though the standard
procedure for this kind of injury is autografting, it could potentially lead to loss of sensory
function and neuroma, leading Fadia et al. (2020) to explore a biodegradable poly(caprolactone)
(PCL) conduit with an inserted double-walled polymeric microspheres that contain GDNF. This
PCL conduit can offer a continuous release of GDNF for more than 50 days in a 5-centimeter
nerve injury in a non-human primate (rhesus macaque). The investigators compared the
PCL/GDNF conduit with a median nerve autograft and a PCL conduit with empty (no GDNF)
microspheres (PCL/empty). Fadia and colleagues (2020) found that the groups with PCL/GDNF
conduit treatment and the autograft-treatment had improved functional recuperation compared to
the PCL/empty treated groups. Additionally, the groups treated with the biodegradable nerve
conduit with encapsulated GDNF have better nerve conduction velocity 1-year post-surgery, and
histological analysis revealed a larger average area inhabited Schwann cells at the distal nerve
when compared to the other two groups (Fadia et al., 2020). This work adds a novel approach on
solving PNIs, especially when a large peripheral nerve gap is present in a non-human primate.
Aim of this project
This work aimed to evaluate structural plasticity changes in MNs by measuring cell body
size and end plates by measuring area size in sedentary Sprague-Dawley rats from young (1month-old) to old (24-month-old) and how does exercise (long-term voluntary-running), starting
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at different time points, have beneficial effects in maintaining structures. Number and frequency
distribution of area size of MNs was also assessed. We hypothesize that MN size and large-sized
MN groups, and end plates size decrease with sedentary-aging but exercise intervention starting
at any age will be able to reverse these effects. Our results indicate that exercised rats had an
average larger size at older ages, higher percent of large-MN groups, and increased size in motor
end plate areas in soleus and plantaris muscle. Number of MNs declined ~ 13% and exercise
maintained the number of MNs in adults.
Based on previous studies, it led us to the question of what happens in the case of longterm exercise and does it have a similar effect starting exercise at different stages throughout the
lifespan of a Sprague-Dawley rat? Our work presents what is the impact of long-term walk
training exercise from 1-month-old to 24-month-old on GDNF protein content and mRNA
expression in skeletal muscle (soleus, plantaris, and gastrocnemius) and protein content on
lumbar spinal cord. We hypothesize that exercise will increase GDNF protein content and
expression in lumbar and muscle tissue. Soleus and plantaris muscle from exercised rats showed
incremented levels of total and concentration of GDNF protein content. Exercise did not have an
effect on GDNF protein content in lumbar spinal cord. GDNF expression increased in
gastrocnemius in 3-month-old exercised group.
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CHAPTER II
METHODS
Animal subjects
The animal protocols used have been approved by the Institution Animal Care and Use
Committee (IACUC). Sprague-Dawley rats are obtained from Charles River from the
psychology department and housed in Western Michigan University’s animal facility. The
Sprague-Dawley rats used in this project were aged from 1 month of age to 3 months and from 6
months to 24 months of age. Rats were classified as the following 1-month-old rats (juvenile), 3and 6-month-old rats (young adults), 12- and 18-month old rats (adult), and 24-month-old rats
(old). Each group age had an n = 6, except for 18 and 24 months of age, which had an n = 5.
Voluntary exercise
The animals were divided in two groups: sedentary-aged group and age-matched
exercised group. Sedentary-aged group was comprised with the following age time points – 1-,
3-, 6-, 12-, 18-, and 24-month-old rats. This group was housed without a running wheel and
limited to the space of their cage. The exercised age-matched group had the following ages – 3,
12, 18 and 24 months of age. The exercised group was housed with a running wheel attachment
with easy access for Sprague-Dawley rats. The running wheel had a sensor attachment that
monitored speed and distance every time the rat used the wheel. The entrance to the running
wheel remained open and readily available for 24 hours/day, 7 days/week. The duration of
exercise in young rats was 10 weeks (1 month => 3 month of age) and for adult and old rats 6
months (long-term exercise) (6 month => 12 month of age; 12 month => 18 month of age; 18
month => 24 month of age).
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Euthanasia
Animals were weighted and then euthanized in a CO2 chamber followed by an incision in
the diaphragm as established in the approved IACUC animal protocol.
Tissue Collection
The target tissues for this study were skeletal muscle (soleus – slow-twitch fiber type,
plantaris – fast-twitch fiber type and gastrocnemius – mixed fibers 50% slow-twitch fiber type)
and spinal cord – lumbar region. Once removed, tissues were rinsed with phosphate buffer saline
(PBS) and separated. Tissues selected for enzyme-linked immunosorbent assay (ELISA) and
RNA extraction were placed on dry ice and then stored in the -80oC until processed. Tissues
selected for immunohistochemistry were fixed overnight with 4% PFA.
Immunohistochemistry – spinal cord
a. Cryoprotecting - The tissue was first fixed in 4% PFA (as explained in Tissue
collection). Following fixation, the tissue was rinsed with PBS and cryoprotection
was performed. Three solutions were made for cryoprotecting: 10%, 20 and 30%
sucrose + PBS solutions. The tissue was first placed in the 10% solution and once the
tissue sank to the bottom of the tube, it was transferred to the 20% and then to the
30% solution. The tissue was frozen in 2-methyl butane with dry ice.
b. Cryostat - Once frozen the spinal cord is placed in the cryostat for around 20 – 30
minutes so it properly acclimates to the temperature. Sample was mounted with OCT
and obtained sections of 20µm and thaw-mount on Histobond slides. Every other
20µm section was chosen for analysis to avoid bias when analyzing tissue. A total of
4 – 6 sections were mounted on each slide.
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c. Staining – Sections were blocked with blocking solution (5% donkey or goat serum
(depending on the 2o antibody), 1% BSA, 0.1% triton X-100, PBS) for 1 hour.
Primary antibodies were diluted in incubation buffer with a concentration of 1:200.
The primary antibody solution was added and incubated overnight.
For MN staining and identifying we followed the criteria by (Wetts and Vaughn,
1996; Friese et al., 2009; Powis and Gillingwater, 2016).
a. Primary Antibodies:
i. Choline acetyltransferase (ChAT) – 1:200 made in Sheep.
ii. Neuronal nuclear protein (NeuN) – 1:200 made in Mouse.
Secondary antibodies were diluted 1:500 and incubate for 2 hours on slides. DAPI
staining was done at a concentration of 1:1000 and incubated for 3 minutes. Slides
were mounted in a 1:1 solution of PBS and glycerol.
d. Motor neuron size – NeuN-positive and ChAT-positive cells were viewed with a
water 60x objective using a NiKon-C2 confocal microscope. The cells were measured
by tracing the area of each one using the Nikon – NIS-Elements C2 software provided
with confocal microscope. Cells counted had to be NeuN- and ChAT-positive with a
visible nucleus. A total of 30-35 cells per each section were measured and the
selection occurred from ventral to dorsal area in the LMC of the ventral horn.
e. Motor neuron numbers – The ventral horn was viewed with a 20x objective. The
NeuN-positive and ChAT-positive cells located in the LMC of the ventral horn were
counted. The cells had to have a visible nuclei. Counting occurred from ventral to
dorsal direction in each horn of every section (two ventral horns in each section) in a
total of four sections per animal.
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Immunohistochemistry – skeletal muscle
The steps are the same as Immunohistochemistry – spinal cord. Sections of skeletal
muscle were 50µm in thickness and cut in a sagittal plane. ɑ-bungarotoxin was used for motor
end plate staining.
f. End plate size – ɑ-bungarotoxin-positive end plates were viewed with a water 60x
objective using a Nikon-C2 confocal microscope. The end plates were measured by
tracing the area of each one using the Nikon – NIS-Elements C2 software provided
with confocal microscope. The end plates considered were at a horizontal plane. A
total of 30-40 end plates per section were measured.
Tissue processing - protein
When processing skeletal muscle and spinal tissue for protein analysis, first the tissue
was weighted and then transferred to dry ice. The tissue was placed in a plastic bag and dipped in
liquid nitrogen. Dry ice was placed under an aluminum plate to maintain cold temperatures and
pulverized with a hammer. The powdered tissue was placed in a sample tube on ice with sample
processing buffer (0.55 M NaCl, 0.02 M NaH2PO4, 0.08 M Na2HPO4, 2 mM EDTA, 0.1 mM
benzethonium chloride, 2 mM benzamidine, 20 KIU/ml aprotinin, 0.5% bovine serum albumin,
and 0.05% Tween-20) and homogenized. The homogenate was transferred to 1.5mL tubes and
spun at 13,000xg for 30 minutes at 4oC. The supernatant is removed, aliquoted, and stored at 80oC.
ELISA
Nunc 96-well plate was bound with monoclonal anti-GDNF (primary antibody; R&D
Systems). For an entire ELISA plate, 20µl of the primary antibody (stock - 500µg/ml) was
diluted in 10mL of PBS to have a working concentration of 1µg/ml and a 100µl of the mix was
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added in each well. The ELISA plate was stored in a humidified chamber and incubated
overnight at room temperature. ELISA plate was washed with wash buffer (PBS with 0.05%
Tween-20). Once washed, the plate was blocked with blocking buffer (PBS with 5% sucrose and
1%BSA) by adding 200µl of blocking solution per well and incubated for 1 hour at room
temperature in a humidified chamber. GDNF protein standards and samples in quadruplicates
were added and incubated for two hours at room temperature in a humidified chamber.
Secondary antibody solution was made by diluting 20µl of antibody in tris buffered saline (TBS)
(10ml of TBS with 10mg BSA and 5µl of Tween-20). A total of a 100µl per well of the
secondary antibody solution was added and incubated overnight in a humidified chamber at
room temperature. The plate was washed and a 100µl per well of substrate solution (10ml of
PBS, 0.1g of BSA, and 50µl of streptavanin for 1 plate) was added and left incubating in a
humidified chamber at room temperature for 40 minutes. After incubation, 100µl per well of
Turbo color reagent was added and incubated for periods of 20 minutes. The reaction is stopped
with the use of 1M HCl by adding 100µl per well. The plate was read in a microplate scanning
spectrophotometer and measured absorbances at 450nm of wavelength. The assay has the ability
of detection as little as 2.0pg/ml of GDNF.
Tissue processing – RNA
Approximately 40-50 mg of gastrocnemius was weighted and used for RNA extraction.
The tissue was placed in a cold mortar, liquid nitrogen was poured on the tissue to maintain
temperature and pulverized with a pestle. The pulverized tissue was placed in an RNase-free tube
with 600µL of TRI-reagent and homogenized with a high-speed bead homogenizer. Zymo
Direct-zol RNA purification kit (Zymo research Direct-zol RNA Miniprep Plus Kit Cat. No.
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R2072) was used to extract RNA from homogenized sample. This kit provides a streamlined
method to extract RNA, no phase separation, precipitation, or post-purification steps are needed.
In short, ethanol (95-100%) was added to equal volume of homogenized tissue and mixed. The
mix was placed in the Zymo-Spin Column and centrifuged. DNase I treatment was added and
then the column was washed. The RNA was eluted with 50µL of DNase/RNase-free water and
verified concentration and purity at the nanodrop. Samples were stored at -80oC.
Efficiency curve generation
For validation of the efficiency of primer/probe sets in the RNA of the sample collected.
The sample was organized in three concentrations 100ng, 30ng, and 10ng. The samples were
placed in triplicates per primer/probe being validated. The primer probes tested were 18sR,
ANKRD, HPT and GDNF. The Cts obtained from each triplicate after running the qPCR were
averaged and a plot of Ct average vs log of ng (2, 1.477, 1) as seen in Graph 1. The graph was
plotted as a scatter and the linear equation was added. The R2 value of the line = efficiency. To
determine the efficiency, the ThermoFischer qPCR Efficiency Calculator Tool was used
(https://www.thermofisher.com/us/en/home/brands/thermo-scientific/molecularbiology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-scientificweb-tools/qpcr-efficiency-calculator.html). Desired efficiencies fall between 90 – 110%.

Graph 1 – Efficiency curve for the selected housekeeping gene 18sR.
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RT-qPCR
Design a template for PCR plate with genes that primer/probes have 90-110% efficiency,
including a no template control and no RT control. The number of samples were determined and
reactions were scaled down to a 10µL according to the SuperScript III Platinum One-Step qRTPCR kit (Invitrogen cat. num. 11732-020). In short, all components found in the kit were thawed
on ice before use. The master mix (MM) was made by combining the 2X reaction mix,
primer/probe, and DNase/RNase-free water in an RNase free tube. The RNA was diluted using
C1V1 = C2V2. The diluted RNA was pipetted (1µL) to the bottom of the plate. The MM gets
completed by adding the SuperScript III RT/Platinum Taq and was pipetted into each reaction
following plate template. The plate was kept on ice until loading into the qPCR machine. The
qPCR data was analyzed by doing a ΔΔCT analysis and compared relative gene expression of
GDNF.
Statistical analysis
Data values are reported as mean ± the standard error of the mean (SEM). Area values are
reported in µm2, GDNF protein values are reported in pg of GDNF (for total amount of protein)
and as pg of GDNF/ mg of wet tissue weight (for concentration of protein in sample). Data were
analyzed using one-way analysis of variance (ANOVA) and Turkey’s post hoc comparison test.
Significance = p values < 0.05.
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CHAPTER III
RESULTS
Weight gain in sedentary rats
Figure 1-A displays weight in sedentary rats. As the rat grows from 3 to 6 months of age
weight also increases. Sprague-Dawley rat growth slows-down and halts between 6 (young
adult) to 12 (adult) months of age. After the 12 month mark, weight stays relatively the same
from 12 to 18 months of age. Weight increases once more from 18 (adult) to 24 (old) months of
age, possibly due to accumulation of adipose tissue as the rat becomes more sedentary with age.
Distance ran
Figure 1-B displays the average measure distance ran by each age group. The mode of
exercise was voluntary walk-training. Rats has access to a running wheel for 24 hours a day 7
days a week for a total of 10 weeks from 1 month of age to 3 months of age and for a total of 6
months in adult and old age. The 3 month old groups ran the most, totaling a distance of
approximately 116.23km. As age increased, the distance ran by the older groups consistently
decreased.
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Figure 1 – Weight gain in sedentary rats and distance ran by exercised groups. Panel A – Weight gain of
Sprague-Dawley rats displaying growth of the animal. Panel B – Distance ran by exercised groups. At the end of
each bar, the average measure distance is displayed.
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Progression of motor neuron structural plasticity with age in lumbar spinal tissue and
effects of exercise
Previous work has explored MN area (µm2) at different time points in the adult rat.
However, what occurs with MNs from juvenile to old age remains understudied. Lumbar spinal
tissue was stained with ChAT and DAPI. ChAT positive cells in the LMC of the ventral spinal
horn were traced to measure the area of the cell bodies as displayed in Figure 2 – C.
MNs gradually increased from 1 month of age (798.9µm2 +/- 37.91) to 6 months of age
(1562 µm2 +/- 121.1) (Figure 2 – A). After 6 months of age, area size declines into adulthood
and old age ( 12 months of age – 949.4 µm2 +/- 92.44, 18 months of age – 476 µm2 +/- 39.42, 24
months of age – 420.6 µm2 +/- 31.49) (Figure 2 – A).
Prior work tested the effects of two weeks of voluntary and involuntary exercise on MN
structural plasticity on 6 and 24 months of age (McCullough et al., 2013). This work explored 10
weeks of voluntary exercise (juvenile) and 6 months of voluntary exercise (young adult - old
rats). The 18- and 24-month-old groups displayed larger MN area size (657.7 µm2 +/- 49.86 and
602.8 µm2 +/- 42.18, respectively) compared to their sedentary counterparts (476.1 µm2 +/39.42 and 420.6 µm2 +/- 31.49, respectively). In the exercised 3- and 12-month-old rats (1079.05
µm2 +/- 61.2 and 1167.56 µm2 +/- 119.93, respectively) there was no change when compared to
their sedentary counterparts (1105.4 µm2 +/- 64.46 and 949.4 µm2 +/- 92.44) (Figure 2 – B).
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Figure 2 – Motor neuron cell body size from sedentary and exercised rats. Panel A – Motor neuron cell body
size was compared in sedentary rats from 1 month of age to 24 months of age. Statistical comparisons of motor
neuron cell body size from lumbar spinal tissue in young rats (1 and 3 months of age) and older rats (6, 12, 18 and
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24 months of age). Panel B – Statistical comparisons of motor neuron cell body size in lumbar spinal tissue from
sedentary and exercised rats. Measured cell body size was larger in exercised older rats compared to their sedentary
counterparts. Panel C – Cell body with ChAT-positive staining (green) and DAPI (blue) in the LMC of the ventral
horn from a 1-month-old rat.

Frequency distribution of MN area size from sedentary and exercised rats
Unfortunately, effective markers for ɑ-MN subtypes (fast-fatigable-, fast-resistant- and
slow-MNs) are not readily available. A criterion used to identify possible fast- vs slow-MNs is
using the area size of the cell (Friese et al., 2009; Kanning et al., 2010; Maxwell et al., 2018).
Fast-fatigable MNs are the largest of the subtypes, while slow-MNs are the smallest of the
subtypes. Histograms of MN size were created for each age group in both sedentary and
exercised rats to evaluate possible MN subtype loss with age and the effects of exercise on
subtype survival. Figure 3 - A-B, D-E, G and I show distribution in sedentary-aged rats and
Figure 3 - C, F, H and J display distribution in exercised rats.
The 1 month-old group (Figure 3 – A) had a bimodal shape displaying two possible
populations of ɑ-MNs. Approximately 50% of cells were between 300 µm2 – 600 µm2 and 37%
of cells were between 750 µm2 – 1500 µm2. The most numerous group was 450 µm2 with 23%
of the total cells that were measured in this group.
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Figure 3 – Frequency distribution of motor neuron size. Panels A-H – Cell size distribution of LMC motor
neurons from lumbar spinal tissue. Frequency histogram depicts number of motor neurons in each size (Y axis;
number of cells in each group. X axis; area in µm2; bin: 150).

The 3 month-old sedentary group (Figure 3 – B) displayed a near unimodal shape with
groups of large cells at the right giving the histogram an almost bimodal behavior. Cells found
between 350 µm2 – 1250 µm2 comprised 79% of measured cells, while the remaining 21% of
cells are located between 1550 µm2 – 2300 µm2. The most numerous group being the 950 µm2
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with 20% of the total cells that were measured. The exercised 3 month-old rats (Figure 3 – C)
histogram was skewed towards the left with 79% of measured cells falling in the 500 µm2 – 1250
µm2 groups and the remaining 21% located between 1400 µm2 – 2900 µm2 groups. Noticeable in
the exercised groups there was a gap between the 2150 µm2 – 2750 µm2 with two outlier groups
of large cells (2750 µm2 – 2900 µm2) at the end of the histogram tail. Exercised 3-month-old rat
group displayed a similar distribution as its sedentary counterpart, with the exception of some
large group of cells not found in the sedentary rats.
At 6 months of age (Figure 3 – D), the histogram was skewed to the left with 85% of
measured cells falling between 250 µm2 – 2250 µm2 and the remaining 15% distributed in small
groups of large cells (>2750 µm2 ). The 6 months of age group displayed the widest variety of
MN cell sizes when compared to all the groups. At 12 months of age (Figure 3 – E), there was a
reduction of cells with area sizes bigger than 3000 µm2 groups displayed at 6 months of age.
The histogram was skewed to the left with 83% of cells located between 300 µm2 – 1500 µm2,
the largest group being the 450 µm2 similar to the 1 month-old group. The 12 month-old
exercised counterpart (Figure 3 – F) was also skewed to the left, with 85% of cells located in the
300 µm2 – 1650 µm2 groups, the largest one also being 450 µm2. The exercised group had the
presence of larger cells compared to the sedentary 12 month-old rats.
At 18 months of age, distribution of motor neurons was skewed to the left with 81% of
cells measured found in groups 300 µm2 – 1050 µm2 with the most numerous group being the
300 µm2 representing 45% of the total cells measured (Figure 3 – G). Interestingly, cells larger
than 2500 µm2, found at 12 months of age, are not present. The exercised counterpart was
skewed to the left with 96% of the measured cells located between 300 µm2 – 1500 µm2, the
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most numerous group being the 300 µm2 with 29% of the totals cells measured. The 450 µm2
was the second largest group with 27% of the total cells measured.
The oldest group (24 month-old rats Figure 3 – I) displayed a histogram skewed to the
left with 88% of measured cells located between 300 µm2 – 900 µm2. The group with most cells
was the 300 µm2 group with 44.5% of the total measured cells. It is worth noting that cells
located in the 150 µm2 group increased compared to other ages (19% of total measured cells).
Exercised 24-month-old rats displayed a distribution skewed to the left with 95% of measured
cells located between 300 µm2 - 1650 µm2. The group with most cells was the 300 µm2 group
with 36% of total measured cells followed by the 450 µm2 group with 19%. The exercised 24month-old rats (Figure 3 – J) had the presence or larger groups of cells compared to the
sedentary 24 month-old rats.
Motor neuron number decline in adults rats and effects of exercise
MNs from the LMC were counted at adult ages (6 months – 24 months of age) in
sedentary and exercised rats. Figure 4 – A displays putative ɑ-MNs from a 6 month-old rat
stained with NeuN (Friese et al., 2009), ChAT and DAPI. Cells with a visible nuclei and positive
staining for both NeuN and ChAT were counted.
Figure 4 – B display statistical comparison of the number of MNs in adult sedentary
animals using the 6-month-old group as the control group for adult and old rats. MN number
declined by 24 months of age, when compared to the 6-month-old young adult (6 month-old –
148.5 +/- 2.35 cells vs 24 month-old – 129.3 +/- 4.9 cells) with a reduction of approximately
13%. When comparing exercised rats to sedentary (Figure 4 – C), exercise did not have a
statistical significance. Noticeably, however, the slope of the regression from the exercised
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animals show a slower decline of cells, looking more similar to the 6-month-old group (Figure 4
– D).

Figure 4 – Number of motor neurons in lumbar spinal cord from sedentary and exercised rats. A - Motor
neurons (white arrows). Cells that were ChAT-positive (green), NeuN-positive (red) and DAPI-positve (blue)
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located in the LMC were counted. The image shows the merge of the three positive stainings. B – Displays
statistical comparisons of motor neuron cell number from lumbar spinal tissue in adult rats (6 months of age) and
older rats (12, 18 and 24 months of age). Motor neuron cell number decreased at 24 months of age compared to 6
months of age. Panel C – Displays statistical comparisons of motor neuron cell body number in lumbar spinal tissue
from sedentary and exercised rats. Exercise had no significant effect on motor neuron cell body number. Panel D –
Progression of changes in motor neuron numbers over time.

Progression of end plates with age in soleus and plantaris and effects of exercise
Changes in NMJ structure was determined by evaluating the area size of end plates.
Figure 5 - A displays end plates from skeletal muscle. Horizontal end plates were measured by
tracing the area of the structure. End plates from soleus muscle (Figure 5 - B) displayed a
progressive increase in area size from 1 month of age to 24 months of age. End plates from
plantaris muscle (Figure 5 - C) displayed a progressive increase in size from 1 month of age to 6
months of age. After 6 months of age, end plates decreased in size until 24 months of age.
Exercised rats displayed increased size in end plates in both soleus and plantaris. In the
soleus muscle, exercise had the more noticeable effect at 12, 18 and 24 months of age. Exercised
3-month-old rats had a similar size as its sedentary counterpart. However, at 12 and 24 months of
age, exercised rats had an increase in end plates area size (Figure 6 A). end plates in plantaris
muscle from exercised rats displayed significant area size increase at all ages where exercise was
present (Figure 6 B).
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Figure 5 – End plate area size in soleus and plantaris muscle from sedentary rats. Panel A – End plate. ɑbungarotoxin conjugated with an alexa-488 was used to stain the postsynaptic receptors (motor end plates). The
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image shows measurement of horizontal motor end plates. Panel B – Statistical comparisons between end plates
area size in soleus muscle from young rats (1 and 3 months of age) and older rats (6, 12, 18 and 24 months of age).
Motor end plate size remains at a similar size at all ages, except at old age where the motor end plate average size
increased. Panel C – Displays tatistical comparisons between motor end plates area size in plantaris muscle from
young rats (1 and 3 months of age) and older rats (6, 12, 18 and 24 months of age). Motor end plate size increases
until 6 months, area size decreases thereafter.

Figure 6 – Effects of exercise on end plate area in soleus and plantaris. Panel A – Statistical comparisons of end
plate area in soleus from sedentary and exercised rats. Panel B – Statistical comparisons of end plate area in
plantaris from sedentary and exercised rats. Motor end plate size increased in soleus from exercised adult rats but no
effect at a young age (3 months). Motor end plate size increased in plantaris from all exercised rats.
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Progression of GDNF protein concentration with age in lumbar spinal tissue and the effects
of exercise
In a prior study GDNF protein content in spinal lumbar tissue was explored following 2
weeks of exercise (McCullough et al., 2013). In this study, GDNF protein concentration (pg of
GDNF/ mg of spinal tissue) (Figure 7 A) after long-term exercise was determined. GDNF
concentration in lumbar spinal tissue was highest at 1 month of age with 3.323 +/- 0.4 pg/mg. By
3 months of age, concentration of GDNF declined (0.9445 +/- 0.03 pg/mg) and remained at
stable levels in adult and old rats. Figure 7 B shows the progression of GDNF concentration
over time in lumbar spinal tissue. The effects of exercise on GDNF protein concentration was
assessed. Exercise did not have a significant effect on GDNF protein concentration, remaining at
similar levels as their sedentary counterparts (Figure 7 C).
GDNF declines with age in skeletal muscle
Previous work (Wehrwein et al., 2002; McCullough et al., 2011; Gyorkos et al., 2014)
explored GDNF protein levels in skeletal muscle at different time points but has not explored the
changes in GDNF levels from young (1 month of age) to old age (24 months of age). GDNF
protein content was evaluated in two muscles: soleus (primarily slow-twitch muscle fibers) and
plantaris (primarily fast-twitch muscle fibers).
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Figure 7 – GDNF protein content in lumbar spinal tissue from sedentary and exercised rats. Panel A –
Concentration of GDNF (pg GDNF/mg spinal tissue) in lumbar spinal tissue was determined from 1 month to 24
months of age. GDNF protein concentration was highest at 1 month of age and dropped at 3 months and remained in
a stable low concentration. Panel B – Progression of changes in GDNF concentration (pg GDNF/mg spinal tissue)
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over time in lumbar spinal tissue. Panel C – Statistical comparisons of GDNF protein concentration (pg GDNF/mg
muscle) in lumbar spinal tissue from sedentary and exercised rats. Exercise had no effect on the GDNF protein
concentration in lumbar spinal cord.

In soleus muscle, the total GDNF protein content (Figure 8 - A) and the concentration of
GDNF in muscle tissue (Figure 8 - B) was determined. The total amount of GDNF refers the
total amount available in the entire tissue. The concentration of GDNF refers to how many pg of
GDNF per mg of wet tissue. The total amount of GDNF in soleus at 1 month of age is
approximately 452 +/- 25.09 pg of GDNF. By the time the rat is 3 months of age, total amount of
GDNF increased to 2795 +/- 284.2 pg. After 3 months of age, total GDNF declines to 1292 +/60.86 pg at 6 months of age and is maintained at a relatively stable level through 12 months of
age (1545 +/- 240.4 pg of GDNF). GDNF levels decline to 408 +/- 54.33 pg at 18 months of age
and 396 +/- 99.51 pg of GDNF at 24 months of age. Figure 8 - C shows the progression of total
GDNF protein content over time in soleus muscle.
The concentration of GDNF protein was high in soleus muscle at 1 (7.405 +/- 0.3 pg/mg)
and 3 (6.792 +/- 0.74 pg/mg) months of age with (Figure 8 - B). GDNF concentration declines
and remains at stable levels in rats at 6 (2.541 +/- 0.09 pg/mg) and 12 (2.664 +/- 0.16 pg/mg)
months of age. As the rat reaches late adult and old age (18 and 24 months of age), GDNF
concentration drops (1.350 +/- .16 pg/mg and 1.314 +/- 0.38 pg/mg, respectively), and remains
stable through 24 months of age. Figure 8 - D shows the progression of GDNF protein
concentration over time in soleus muscle.
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Figure 8 – GDNF protein content from soleus muscle from sedentary rats. Panels A – Statistical comparisons
of total GDNF protein content (pg GDNF) in soleus muscle from 1 month to 24 months of age. Total muscle GDNF
protein increases from 1 month to 3 months of age and decreases at older ages (6, 12 and 18 months). Panel B –
Statistical comparisons of concentration of GDNF (pg GDNF/mg muscle) in soleus muscle from 1 month to 24
months of age. GDNF protein concentration is at its highest at 1 and 3 months of age and a steep decline into
adulthood and remained at low concentration levels at old ages (18 and 24 month). Panels E and F – Progression of
changes in GDNF content (Panel C) and concentration (Panel D) over time in soleus muscle.

In plantaris muscle, the total GDNF protein content (Figure 9 - A) and the concentration
of GDNF (Figure 9 - B) was determined. Total GDNF protein content in plantaris is high at 1
and 3 months of age (1196 +/- 95.71 pg of GDNF and 1273 +/- 102.7 pg of GDNF,
respectively). Total GDNF protein content drops by 6 months of age (380.3 +/- 80.79 pg of
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GDNF) and remained at stable levels until old age. Figure 9 – C shows the progression of
GDNF protein content over time in plantaris muscle.
GDNF protein concentration (Figure 9 – B) was highest at 1 month of age (10.59 +/0.85 pg/mg) and by 3 months of age the concentration declined (6.525 +/- 0.27 pg/mg).
Concentration declined at 6 and 12 months of age (1.636 +/- 0.36 pg/mg and 2.214 +/- 0.2
pg/mg, respectively). At 18 and 24 months of age GDNF concentration declined and stayed at
relatively the same level (0.8404 +/- 0.07 pg/mg and 1.096 +/- 0.29 pg/mg, respectively). Figure
9 – D shows the progression of GDNF protein concentration over time in plantaris muscle.

Figure 9 - GDNF protein content from plantaris muscle from sedentary rats. Panel A - Statistical comparisons
of GDNF protein content (pg GDNF) from plantaris muscle from 1 month to 24 months of age. Total muscle GDNF
remains at high levels from 1 month to 3 months of age and decreases thereafter (6, 12, 18 and 24 months of age).
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Panel B – Statistical comparisons of concentration of GDNF (pg GDNF/mg muscle) in plantaris muscle was
determined from 1 month of age to 24 months of age. GDNF protein concentration is at its highest at 1 month of age
quickly drops by 3 months of age and a steeper drop after 3 months of age until old age. Panels C and D –
Progression of changes in GDNF content (Panel C) and concentration (Panel D) over time in plantaris muscle.

GDNF protein content and concentration comparison between soleus and plantaris
muscles was assessed (Figure 10 A-D). Total GDNF protein content (Figure 10 – A) in soleus is
significantly lower (452 +/- 25.09 pg of GDNF) compared to plantaris (1196 +/- 95.71 pg of
GDNF) at 1 month of age. By 3 months of age, however, soleus GDNF protein content increases
(2795 +/- 284.2 pg of GDNF) and is higher than plantaris (1273 +/- 102.7 pg of GDNF), which
stayed similar to the 1 month of age group. At young adult and adult ages (6 and 12 months),
GDNF protein content decreased in both muscles, but stayed at significantly higher levels in
soleus (1292 +/- 60.86 pg and 1545 +/- 240.4 pg of GDNF, respectively) compared to plantaris
(380.3 +/- 80.79 pg and 452 +/- 22.1 pg of GDNF, respectively). At late adult and old age (18
and 24 months), GDNF protein content in both muscles declined and was at a similar levels.
Figure 10 – B shows the progression of GDNF protein content over time in both soleus and
plantaris muscle.
GDNF protein concentration (Figure 10 – C) in plantaris muscle (10.59 +/- 0.85 pg/mg)
was higher than in soleus muscle (7.405 pg/mg) at 1 month of age. By 3 months of age, the
concentration stayed similar to 1 month in the soleus muscle (6.792 +/- 0.74 pg/mg) and declined
in plantaris (6.525 +/- 0.27 pg/mg). The concentration of GDNF was similar in both muscles at 3
months of age. In both muscles, the concentration of GDNF faced a similar fate of decline by
adult and old ages and interestingly stayed at a similar levels in both muscles. Figure 10 – D
shows the progression of GDNF protein concentration over time in both soleus and plantaris
muscle.
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Figure 10 – GDNF protein content comparison between soleus and plantaris. A and B – GDNF protein content
(pg GDNF) comparison of soleus and plantaris muscle was determined from 1 month to 24 months of age. Panel A
– Statistical comparisons between content in age-paired soleus and plantaris muscle. Panel B – Progression of
changes in GDNF content over time in soleus and plantaris muscle. Total muscle GDNF is higher in plantaris at 1
month of age and by 3 months GDNF is higher in soleus. GDNF drops after 3 months of age, but at a slower rate in
soleus compared to plantaris. C and D – Concentration of GDNF (pg GDNF/mg muscle) in soleus and plantaris
muscle was determined from 1 month of age to 24 months of age. C - Statistical comparisons between GDNF
concentrations in age-paired soleus and plantaris muscle. Panel D – Progression of changes in GDNF concentrations
over time in soleus and plantaris muscle. GDNF concentration is highest at 1 month of age and falls thereafter (3, 6,
12, 18 and 24 months) in both muscles.

Exercise is a stimulus for increased GDNF protein in muscle
Previous work explored effects of 2 weeks of exercise (both voluntary and involuntary)
on GDNF protein in muscle (McCullough et al., 2011; Gyorkos et al., 2014). After analyzing the
progression of GDNF with age in rat skeletal muscle, effects of long-term exercise (10 weeks in
young rats and 24 weeks in adult and old rats) beginning at different ages was explored. The
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effects of exercise on GDNF protein content and concentration was determined in soleus and
plantaris muscle (Figure – 11).
In soleus muscle (Figure 11 A and B), GDNF protein content increased in exercised rats
at 3 months (2795 +/- 284.2 pg of GDNF in the sedentary rat vs 4732 +/- 364 pg of GDNF in the
exercised rat) and 24 months of age (395.9 +/- 99.51 pg of GDNF in the sedentary rat vs 1257
+/- 118.6 pg of GDNF in the exercised rat) (Figure 11 A). Exercised rats had a similar trend in
GDNF protein concentration (Figure 11 B). At 3 months (6.792 +/- 0.74 pg/mg in sedentary rats
vs 11.72 +/- 0.9 pg/mg in exercised rats) and 24 months of age (1.314 +/- 0.38 pg/mg in
sedentary rats vs 3.461 +/- 0.17 pg/mg in exercised rats) exercised rats had increased GDNF
protein concentration.
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Figure 11 – Effects of exercise on GDNF protein content and concentration in soleus and plantaris. Panel A –
Statistical comparisons between GDNF protein content (pg GDNF) in soleus muscle from sedentary versus
exercised rats (3, 12, 18 and 24 months of age). Panel B – Statistical comparisons of GDNF protein concentration
(pg GDNF/mg muscle) in soleus from sedentary and exercised rats. Panel C – Statistical comparisons between
GDNF protein content (pg GDNF) in plantaris muscle from sedentary versus exercised rats (3, 12, 18 and 24 months
of age). Panel D – Statistical comparisons of GDNF protein concentration (pg GDNF/mg muscle) in plantaris from
sedentary and exercised rats. GDNF protein content and concentration increased in exercised animals compared to
their sedentary counterparts.

In plantaris muscle (Figure 11 C and D), GDNF protein content stayed at the same level
in both sedentary and exercised rats at 3 months of age, but increased at adult and old ages. At 12
months of age, GDNF protein content in exercised rats was 1172 +/- 102.8 pg of GDNF versus
its sedentary counterpart that was 452 +/- 22.1 pg of GDNF. At 18 months of age, exercised rats
had 745.8 +/- 33.43 pg of GDNF versus sedentary rats that had 454.9 +/- 60.36 pg of GDNF.
Exercised 24-month-old rats had 532.7 +/- 54.93 pg of GDNF versus sedentary rats with 262.1
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+/- 60.15 pg of GDNF (Figure 11 C). Exercise had a similar effect on GDNF protein
concentration. Exercised rats at 12, 18 and 24 months of age had increased concentration, while
3 months stayed similar to its sedentary counterpart (Figure 11 D).
Relative gene expression of GDNF with aging and the effects of exercise
Gastrocnemius muscle was used to study relative gene expression of GDNF in sedentaryaging. Gastrocnemius is a mixed fiber type muscle, with 50% of its muscle fibers being slowtwitch fibers making it predominantly a slow-twitch muscle (Edgerton et al., 1975). To study
relative gene expression of GDNF, 40-50 mg of muscle tissue was used to extract RNA as
described in the methods. The rat group used as control was the 1 month-old rat group (youngest
group). The control group was identified with a Fold=1. GDNF expression increased 18-fold at 6
months of age (early adult) and dropped at at 24 months of age (Figure 12 A). At 24 months,
expression decreased to 0.39-fold compared to the control group.
The effects of exercise on GDNF gene expression was assessed. For each pair (sedentary
rat versus exercised rat), the sedentary groups served as the control group (Fold = 1) (Figure 12
B). Our results indicate that GDNF expression significantly increased in exercised 3 month-old
rats (161.7 fold increase). At adult ages and old ages, exercise did not have a significant effect.
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Figure 12 – Relative gene expression of GDNF in gastrocnemius. Panel A – Relative expression of GDNF gene
in gastrocnemius from sedentary rats. GDNF expression from sedentary rats (3 months to 24 months of age) were
compared to 1 month old sedentary rats (control group Fold = 1). GDNF expression increased at 6 months of age
and dropped in the subsequent ages. Panel B – Relative expression of GDNF in gastrocnemius from sedentary and
exercised rats. Sedentary rats acted as control groups (Fold = 1) compared to the exercised groups. Exercised rats
had increased GDNF expression compared to sedentary rats at 3 months of age.
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CHAPTER IV
DISCUSSION
Effects of sedentary-aging and exercise on structural plasticity of motor neurons in lumbar
spinal cord and end plates of hindlimb muscle
Changes in structural plasticity in motor neurons across time
Plastic changes in MNs as an organism ages remains a topic of interest due to conflicting
views of what actually occurs with these cells (Tomlinson and Irving, 1977; Jacob, 1998;
Kanning et al., 2010; Maxwell et al., 2018). Results from previous studies done in models of
aging reported a selective atrophy of large-sized MNs and a decline in the total number of
available MNs that innervate hindlimb skeletal muscles (Hashizume and Kanda, 1990; Hirofuji
et al., 2000; McCullough et al., 2013). This study explored chronological changes in the size of
ɑ-motor neurons (NeuN-positive cells in the LMC of the ventral horn) (Friese et al., 2009) in
young (1 month of age) to old (24 months of age) Sprague-Dawley rats.
It is of importance to note that the groups used to track effect of aging on MNs were
sedentary rats (no access to running wheels). Our results uncover that in the first 6 months of age
cell body size significantly increases. A Sprague-Dawley rat reaches sexual maturity by 10
weeks of age (start of adulthood) and growth continues and slows down by 6 – 12 months of age
(Brower et al., 2015; Ghasemi, Asghar; Sajad, 2021) as evidenced by weight (g) of the rat. After
6 months of age, the size of measured cells at 12, 18 and 24 months of age declined in every
group. Cell body size increase in the first 6 months of age could be attributed to the continued
growth of the animal. As the animal matures, tissues innervated by these cells (skeletal muscle)
continue to grow, which could drive the continued increase in cell body size of MNs. The decline
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in cell size in groups older than 6 months of age suggest MN cell body size does decrease with
increased age. Decline in cell size could be attributed to a loss of GDNF support at later ages
from the target tissue being skeletal muscle as seen in Figure 8-E and 9-E. Another possible
explanation for this change in size with age is atrophy and weakening of MNs. Previous work
has showed more atrophied MNs at old age when compared to a young adult (McCullough et al.,
2013). Lack of trophic support could cause weakening of MNs leading to a loss in shape leading
to a more reduced size.
Previous work has described that at older ages, there is tendency to lose MNs,
particularly large MNs. A lack of effective molecular markers hinder our ability to detect
specific subtypes of ɑ-MNs; however, within the subtypes of ɑ-MNs, the fast-fatigable- and fastresistant- MNs are the least numerous and the largest in size (Stifani, 2014). Histograms were
created to analyze the cell body size distribution of the measured cells. By doing so, we were
able to determine if there were shifts in distribution of MN cell sizes with age and exercise. Rats
from our adult and old age groups displayed the greatest shift in cell size distributions, with
declines in the number of cells measuring over 1500 µm2. These declines in cell size was more
noticeable at 24 months of age. Interestingly enough, previous work has seen fast-type muscle
fibers tend to atrophy first with age possibly linked to a loss of fast-type MNs (Deforges et al.,
2009; Kanning et al., 2010). These leads us to think that another possible reason for the average
cell size measurements becoming smaller with age is due to a loss of large MN groups (possibly
fast-type MNs) as evidenced by histograms in Figure 3 – A, G, I.
After evaluating the structure of MNs in the LMC of the ventral horn, the number of
MNs were counted. NeuN-positive (Friese et al., 2009) and ChAT-positive cells (Wetts and
Vaughn, 1996) found in the LMC of the ventral horn were taken into consideration as ɑ-MNs
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(Powis and Gillingwater, 2016). Previous work by Piekarz et al. noticed a 41% reduction of ɑMNs in old mice (Piekarz et al., 2020). Our results indicate that at old age (24 months) in
sedentary animals there was a reduction of approximately 13% in the number of ɑ-MNs when
compared to the young adult rat (6 months). Exercised rats, although not statistically significant,
had a higher MN count compared to sedentary animals, suggesting that age did not have an
effect on exercised animals thus maintaining number of cell through old age.
Past work has explored the effects of two weeks of exercise using various modalities
(voluntary running, involuntary running and swimming) at 6 and 24 months of age. In that study,
exercised rats displayed an increase in MN size compared to their sedentary counterparts
(McCullough et al., 2013). Based on those results, we explored the effects of long-term voluntary
exercise as described in the methods section. Exercise had the greatest effect at late adult and old
age (18 and 24 months of age). At these time points, exercised rats displayed a significant
increase in MN size compared to their sedentary counterparts. Increase in the average size of
measured cells may indicate that increase in physical activity can maintain and restore MNs.
Neurogenesis in the spinal cord does not exist, as far as we know, so instead of creating new
cells, the structure of the cell regains shape appearing healthier. Restoration in structure could
lead to increase in cell body size. Trophic support, in the form of GDNF, also increased in
skeletal muscle of exercised animals, most noticeably in the adult and old ages (Figure 11). This
increase of GDNF could be linked to maintaining cells innervating muscle fibers that are more
active, thus maintaining their shape and not becoming atrophied.
Changes in structural plasticity in end plates across time
The area of end plates was measured to evaluate changes that occur with sedentary-aging
in a primarily slow-type muscle fiber muscle (soleus) and primarily fast-type muscle fiber
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muscle (plantaris). Measured end plates in the soleus muscle increased from young to old. This
increase in end plate does not necessarily mean it is a more efficient end plate. End plates at
older ages appeared more fragmented and larger spaces inside of the plate, this could suggest
deterioration of this structure. Plantaris muscle, however, after the 6 month time point showed
signs of declining area size. The most noticeable decline occurred at old ages (18 and 24
months). A possible reason for this could be a muscle fiber type change with age. Sprouting of
existing MNs can occur when an end plate is not occupied suggested to trigger a muscle fiber
type change. Because MNs that innervate fast-type muscles are suggested to be affected by age,
it could be possible that in the plantaris muscle, at older ages, shifts towards a slow-type fiber.
Leading us to suggest that end plate size decrease after 6 months of age is due to a muscle
phenotype change because of changes in innervation from subtypes of MNs. Another possibility
for the reduction of end plate size in adult and old ages is atrophy of this structures due to
inactivity and loss of innervation. This loss of innervation could be also associated with loss of
MN subtypes. Our results show that MN area size with time (Figure 2 – A and B) and end plate
area size from plantaris (Figure 5 – D and E) behave in a similar fashion, further strengthening
our explanation.
Animals that exercised showed increased end plate area size in both soleus and plantaris
muscle. In soleus muscle, the exercised 12 and 24 month-old rats displayed a significant
increase, while the 18 month-olds displayed a non-significant increase in end plate size. On the
other hand, plantaris muscle from exercised rats had increased end plate size at all ages where
exercised was introduced. Previous work conducted by Gyorkos et al. explored the effects of
various modes of exercise (voluntary running, involuntary running and swimming) for the extent
of 2 weeks. End plate size increased in soleus (particularly in the swimming group) compared to
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the sedentary group. Our results show a similar behavior on end plate size, most noticeable at
older ages suggesting exercise is able to modify post-synaptic structures agreeing with similar
findings in alterations of end plates with exercise in rats (Deschenes et al., 1993; McCullough et
al., 2011; Gyorkos et al., 2014). Altogether, remodeling of postsynaptic structures could be
attributed to pre-synaptic changes, as seen with changes in MN structure, groups and numbers.
Increase in activity, via exercise, is possibly triggering an activity-dependent-type mechanism
where stores of neurotransmitters, quantal stores and release increment (Dorlöchter et al., 1991).
These increments are possibly triggering the enlargement of end plates (zone of acetylcholine
receptors).
Effects of sedentary-aging and exercise on GDNF protein content and expression in skeletal
muscle and lumbar spinal cord
Changes in GDNF protein content in skeletal muscle and lumbar spinal tissue
across time
Muscle- derived GDNF serves as a potent neurotrophic factor for regulating MN survival
by preventing apoptosis during development in vivo, decreases the loss of MNs in models of
motor neuropathy and chronic degeneration (Henderson et al., 1994; Li et al., 1995; Oppenheim
et al., 1995b; Trupp et al., 1995; Cintrón-Colón et al., 2020). Prior work, using various
modalities of exercise, has explored activity-dependent production of GDNF in both spinal and
muscle tissue (Wehrwein et al., 2002; McCullough et al., 2011, 2013; Gyorkos et al., 2014; Park
and Höke, 2014).
Our study tracked the progression of GDNF protein content from 1 month of age to 24
months of age in both lumbar spinal tissue and skeletal muscle. In both soleus and plantaris
muscle from sedentary animals, total GDNF protein content and concentration are highest at
early ages (1 and 3 months of age) and lowest at late young adult, adult and old ages (6 to 24
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months of age). In plantaris muscle, there is a higher concentration of protein at 1 month of age
and quickly drops by 3 months of age. The concentration at 1 month of age in plantaris muscle is
higher than in soleus at the same age. Plantaris is a primarily fast-type muscle being innervated
by large fast-type MNs. The high concentration of GDNF, particularly in plantaris, at 1 month
suggests higher levels of GDNF are needed for synapse maintenance. Additionally, large MNs
might require larger quantity of GDNF at an early age to maintain connectivity as the animal
matures. By 3 months of age, GDNF concentration is lower in plantaris but in soleus it remains
relatively similar to the 1 month of age group. This suggests that muscle-derived GDNF protein
is more stable in slow-type muscle versus fast-type muscle.
The total amount of GDNF protein in in both muscles was higher at 3 months of age,
more noticeably in soleus. This increase could be attributed to the growth of tissues, as the
muscle grows, there is more available GDNF protein but a decrease in GDNF concentration per
mg of muscle tissue. Total amount of GDNF protein in soleus muscle was maintained at higher
levels when compared to plantaris, until late adult and old age (18 and 24 months of age). In the
late adult and old ages total GDNF protein content was the same as plantaris. This further leads
us to suggest that GDNF protein content in slow-type muscle does remain at higher levels
compared to fast-type muscle. Maintenance of higher available GDNF protein in slow-type
muscle could be associated with maintenance of slow-type MNs, while less available GDNF
protein as seen with plantaris (fast-type muscle) is associated with atrophy and possible loss of
large fast-type MNs. Our results show a decrease in the average measured size of MNs
particularly at the older adult ages and loss of large MN groups at late adult and old ages. These
findings go on par with the progress of total amount of GDNF available in muscle with time,
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further strengthening the possible relationship of available GDNF protein from a target tissue
(skeletal muscle) and MN maintenance and survival.
GDNF protein concentration in spinal cord was highest at 1 month of age and quickly
dropped by 3 months of age and remained at a stable low-level for the rest of ages. The GDNF
concentration in plantaris and soleus at 1 month of age is higher compared to the spinal cord.
This leads us to suggest that muscle-derived GDNF plays a more important role on MNs
innervating skeletal muscle versus spinal-derived GDNF.
Exercised groups displayed higher amount of GDNF protein and concentration in skeletal
muscle but had no effect in spinal cord. These results suggest that GDNF has an activitydependent mechanism in muscle as physical activity increases at late adult and old age.
Additionally, starting exercise at various time points does have a positive effect of increased
trophic factor production. Past work noticed a significant increase in GDNF protein in lumbar
tissue with only 2 weeks of exercise (short-term) at 6 and 24 months of age (McCullough et al.,
2013) but long-term did not increase GDNF protein content. Possibly exercise triggers higher
GDNF protein production in spinal tissue in the initial period of exercise, specially going from
sedentary to exercise, but when exercise regimen is extended protein content lowers due to
supply from target tissues (skeletal muscle). Taken together, GDNF from skeletal muscle might
be a bigger influencer than spinal-derived GDNF on MN health; and exercise is a favorable
method of increasing endogenous trophic factor content to maintain a healthier MN to muscle
connection.
Changes in GDNF expression in skeletal muscle
Relative expression of GDNF was studied in gastrocnemius muscle. Results show
increased expression at 6 months when compared to the 1-month-old group but decreased
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thereafter. In plantaris and soleus muscle total protein content was highest at 3 months of age and
GDNF protein concentration was highest at 1 month of age but by 6 months in both muscles
GDNF protein declined compared to younger ages. In the case of gastrocnemius GDNF
expression was highest at 6 months, when using the 1-month-old group as the control. These
contradictory results could be due to muscle fiber type composition. Soleus and plantaris are
either primarily slow-type or fast-type, respectively, while gastrocnemius has a mixed fiber type
composition. However, after 6 months of age, expression declines and behaving more similar to
protein content from soleus and plantaris. In exercised animals, GDNF expression increased at 3
months compared to sedentary, and, although not significant, GDNF was at relatively higher
folds in exercised animals vs sedentary animals. Increase in GDNF expression in exercised
animals adds more evidence suggesting that GDNF acts in activity-dependent fashion in skeletal
muscle.
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CHAPTER V
CONCLUSION AND FUTURE EXPERIMENTS
Our findings suggest that starting long-term exercise at different time points aid in
neuroprotection by conserving size of MNs, large-MN groups, and number of MNs compared to
sedentary animals at adult ages. Furthermore, end plate size increased in exercised animals.
GDNF protein expression may act in an activity-dependent fashion and GDNF protein content
can increase in slow-(soleus) and fast-(plantaris) fiber type muscles. Surprisingly, GDNF protein
concentration did not increase with exercise in lumbar spinal tissue.
The mode of exercise was long-term voluntary exercise, it will be interesting to evaluate
long-term exercise with various modalities of physical activity, including weight training.
Further studies are needed to understand if in long-term periods there are cyclical changes with
GDNF that could explain why GDNF did not increase in lumbar spinal tissue. Evaluating muscle
fiber type change with time would aid to better understand the loss of either size or subtype of
MNs. Furthermore, studying changes in peripheral nerves, more specifically motor axons, that
innervate hindlimb muscles would aid in understanding what occurs with muscle to nerve
connection with age and how does exercise impact those changes.
Altogether, exercise seems to act as an encouraging method to slow-down effects of
aging and enhance plasticity. A possibility of this, is increased release of neurotrophic factor
from the target tissue. GDNF increase with exercise could lead to healthier contact between
nerve and muscle aiding in healthier senescence. Exploring what is the proper amount of
exercise and mode of exercise can facilitate in prescribing proper exercise regimens in old
individuals or individuals with peripheral nerve injuries. In the case of peripheral nerve injuries,
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in addition for a proper exercise prescription, proper exogenous addition of GDNF to accelerate
repair is worth exploring. Figure 13 displays a summary of the findings from my work in this
project.

Figure 13 – Summary. Panel A – Effects of sedentary-aging on MN area, groups and number, end plate size,
GDNF total protein content and concentration,, and gene expression. Panel B – Effect of exercise interventions on
MN area, groups and number, end plate size, GDNF total protein content and concentration,, and gene expression.
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